David M. Schwope

1.2k total citations
24 papers, 1.0k citations indexed

About

David M. Schwope is a scholar working on Pharmacology, Toxicology and Pathology and Forensic Medicine. According to data from OpenAlex, David M. Schwope has authored 24 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pharmacology, 20 papers in Toxicology and 9 papers in Pathology and Forensic Medicine. Recurrent topics in David M. Schwope's work include Cannabis and Cannabinoid Research (22 papers), Forensic Toxicology and Drug Analysis (20 papers) and Alcohol Consumption and Health Effects (9 papers). David M. Schwope is often cited by papers focused on Cannabis and Cannabinoid Research (22 papers), Forensic Toxicology and Drug Analysis (20 papers) and Alcohol Consumption and Health Effects (9 papers). David M. Schwope collaborates with scholars based in United States, France and Netherlands. David M. Schwope's co-authors include David A. Gorelick, Marilyn A. Huestis, Erin L Karschner, Garry Milman, Marilyn A. Huestis, Eugene W Schwilke, Robert S. Goodwin, Karl B. Scheidweiler, Deanna L. Kelly and Allan J. Barnes and has published in prestigious journals such as Clinical Chemistry, Clinica Chimica Acta and Analytical and Bioanalytical Chemistry.

In The Last Decade

David M. Schwope

24 papers receiving 967 citations

Peers

Countries citing papers authored by David M. Schwope

Since Specialization

Citations

This map shows the geographic impact of David M. Schwope's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Schwope with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Schwope more than expected).

Fields of papers citing papers by David M. Schwope

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. Schwope. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Schwope. The network helps show where David M. Schwope may publish in the future.

Co-authorship network of co-authors of David M. Schwope

This figure shows the co-authorship network connecting the top 25 collaborators of David M. Schwope. A scholar is included among the top collaborators of David M. Schwope based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David M. Schwope. David M. Schwope is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Widespread Distribution of Xylazine Detected Throughout the United States in Healthcare Patient Samples 2023 ·Journal of Addiction Medicine ·(unknown), David M. Schwope, (unknown), (unknown), Rebecca Heltsley	27
2	Presence of Parent Cocaine in the Absence of Benzoylecgonine in Urine† 2018 ·Journal of Analytical Toxicology ·(unknown), (unknown), (unknown), Rebecca Heltsley, David M. Schwope	4
3	Determining Zolpidem Compliance: Urinary Metabolite Detection and Prevalence in Chronic Pain Patients 2014 ·Journal of Analytical Toxicology ·David M. Schwope, Anne Z. DePriest, David L. Black, Yale H. Caplan, Edward J. Cone, Rebecca Heltsley	9
4	Evaluation of the on-site Draeger DrugTest 5000 in occasional and chronic frequent smokers following controlled cannabis smoking 2013 ·Marilyn A. Huestis, Garry Milman, Damodara Rao Mendu, (unknown), Allan J. Barnes, David M. Schwope, David A. Gorelick, Nathalie A. Desrosiers	2
5	In Vitro Stability of Free and Glucuronidated Cannabinoids in Blood and Plasma Following Controlled Smoked Cannabis 2013 ·Clinical Chemistry ·Karl B. Scheidweiler, David M. Schwope, Erin L Karschner, Nathalie A. Desrosiers, David A. Gorelick, Marilyn A. Huestis	48
6	Cannabinoids and metabolites in expectorated oral fluid following controlled smoked cannabis 2012 ·Clinica Chimica Acta ·Garry Milman, David M. Schwope, David A. Gorelick, Marilyn A. Huestis	48
7	Predictive model accuracy in estimating last Δ9-tetrahydrocannabinol (THC) intake from plasma and whole blood cannabinoid concentrations in chronic, daily cannabis smokers administered subchronic oral THC 2012 ·Drug and Alcohol Dependence ·Erin L Karschner, David M. Schwope, Eugene W Schwilke, Robert S. Goodwin, Deanna L. Kelly, David A. Gorelick, Marilyn A. Huestis	35
8	Tolerance to Effects of High-Dose Oral Δ9-Tetrahydrocannabinol and Plasma Cannabinoid Concentrations in Male Daily Cannabis Smokers 2012 ·Journal of Analytical Toxicology ·David A. Gorelick, Robert S. Goodwin, Eugene W Schwilke, David M. Schwope, W. D. Darwin, Deanna L. Kelly, Robert P. McMahon, Fang Liu, Catherine Ortemann‐Renon, (unknown), Marilyn A. Huestis	62
9	Psychomotor Performance, Subjective and Physiological Effects and Whole Blood 9-Tetrahydrocannabinol Concentrations in Heavy, Chronic Cannabis Smokers Following Acute Smoked Cannabis 2012 ·Journal of Analytical Toxicology ·David M. Schwope, Wendy M. Bosker, Johannes G. Ramaekers, David A. Gorelick, Marilyn A. Huestis	82
10	Cannabinoid Disposition in Oral Fluid after Controlled Smoked Cannabis 2012 ·Clinical Chemistry ·Dayong Lee, David M. Schwope, Garry Milman, Allan J. Barnes, David A. Gorelick, Marilyn A. Huestis	56
11	On-Site Test for Cannabinoids in Oral Fluid 2012 ·Clinical Chemistry ·Nathalie A. Desrosiers, Dayong Lee, David M. Schwope, Garry Milman, Allan J. Barnes, David A. Gorelick, Marilyn A. Huestis	42
12	Cannabinoid Stability in Authentic Oral Fluid after Controlled Cannabis Smoking 2012 ·Clinical Chemistry ·Dayong Lee, Garry Milman, David M. Schwope, Allan J. Barnes, David A. Gorelick, Marilyn A. Huestis	50
13	Postmortem redistribution of Δ9-tetrahydrocannabinol (THC), 11-hydroxy-THC (11-OH-THC), and 11-nor-9-carboxy-THC (THCCOOH) 2011 ·Forensic Science International ·Michael Holland, David M. Schwope, Robert Stoppacher, (unknown), Marilyn A. Huestis	31
14	Antagonist-Elicited Cannabis Withdrawal in Humans 2011 ·Journal of Clinical Psychopharmacology ·David A. Gorelick, Robert S. Goodwin, Eugene W Schwilke, David M. Schwope, W. D. Darwin, Deanna L. Kelly, Robert P. McMahon, Fang Liu, Catherine Ortemann‐Renon, (unknown), Marilyn A. Huestis	12
15	Direct quantification of cannabinoids and cannabinoid glucuronides in whole blood by liquid chromatography–tandem mass spectrometry 2011 ·Analytical and Bioanalytical Chemistry ·David M. Schwope, Karl B. Scheidweiler, Marilyn A. Huestis	91
16	Cannabinoids and metabolites in expectorated oral fluid after 8 days of controlled around-the-clock oral THC administration 2011 ·Analytical and Bioanalytical Chemistry ·Garry Milman, Allan J. Barnes, David M. Schwope, Eugene W Schwilke, Robert S. Goodwin, (unknown), David A. Gorelick, Marilyn A. Huestis	25
17	Identification of Recent Cannabis Use: Whole-Blood and Plasma Free and Glucuronidated Cannabinoid Pharmacokinetics following Controlled Smoked Cannabis Administration 2011 ·Clinical Chemistry ·David M. Schwope, Erin L Karschner, David A. Gorelick, Marilyn A. Huestis	149
18	Disposition of Cannabinoids in Oral Fluid after Controlled Around-the-Clock Oral THC Administration 2010 ·Clinical Chemistry ·Garry Milman, Allan J. Barnes, David M. Schwope, Eugene W Schwilke, W. D. Darwin, Robert S. Goodwin, Deanna L. Kelly, David A. Gorelick, Marilyn A. Huestis	39
19	Δ9-Tetrahydrocannabinol (THC), 11-Hydroxy-THC, and 11-Nor-9-carboxy-THC Plasma Pharmacokinetics during and after Continuous High-Dose Oral THC 2009 ·Clinical Chemistry ·Eugene W Schwilke, David M. Schwope, Erin L Karschner, Ross H. Lowe, W. D. Darwin, Deanna L. Kelly, Robert S. Goodwin, David A. Gorelick, Marilyn A. Huestis	87
20	Detection and quantification of low levels of benzoylecgonine in equine urine 2007 ·Forensic Science International ·(unknown), (unknown), Marc Benoit, (unknown), (unknown), (unknown), David M. Schwope, R. E. Gaensslen, Adam Negrusz	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact